Cite
MLA Citation
P. Jain et al.. “COMBINATION OF IBRUTINIB WITH RITUXIMAB (IR) IS HIGHLY EFFECTIVE IN PREVIOUSLY UNTREATED ELDERLY (>65 YEARS) PATIENTS (PTS) WITH MANTLE CELL LYMPHOMA (MCL) – PHASE II TRIAL.” Hematological oncology, vol. 37, n.d., p. 42. http://access.bl.uk/ark:/81055/vdc_100086209591.0x00003f